BIOMATERIALS LIABILITY REFORM COULD SEE EARLY ACTION IN 104th UNDER TORT REFORM, RAMSTAD SAYS; HCFA COVERAGE OF DEVICES IN CLINICALS ALSO A PRIORITY
This article was originally published in The Gray Sheet
Executive Summary
Biomaterials liability reform legislation could see early action next year as part of a Republican tort reform measure, Rep. Jim Ramstad (R-Minn.) said Dec. 14 at the Food and Drug Law Institute's annual conference in Washington, D.C.